population found that roughly 70% of the non-institutionalized population had 25-hydroxyvitamin D levels below about 30 ng/mL
Peptides designed for metabolic support are gaining attention for their ability to enhance fat metabolism, improve energy utilization, and support healthier body composition
Inhibition of influenza infection by glutathione
Stored at -20C in a freezer, lyophilized retatrutide remains stable for well over a year
On 24 November 2025, Novo Nordisk reported that oral semaglutide had failed to slow Alzheimers disease in the EVOKE and EVOKE+ trials, which together enrolled 3,808 participants and stand as the largest evaluation of this drug class in any neurodegenerative condition [1]
Lab research has long hinted at this, and clinical studies now back up the health benefits of restoring these compounds